1. Home
  2. SHEN vs MRVI Comparison

SHEN vs MRVI Comparison

Compare SHEN & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shenandoah Telecommunications Co

SHEN

Shenandoah Telecommunications Co

HOLD

Current Price

$10.87

Market Cap

543.5M

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.70

Market Cap

449.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHEN
MRVI
Founded
1902
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
543.5M
449.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SHEN
MRVI
Price
$10.87
$3.70
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$26.00
$4.54
AVG Volume (30 Days)
300.6K
1.3M
Earning Date
10-29-2025
11-06-2025
Dividend Yield
0.92%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$351,674,000.00
$192,435,000.00
Revenue This Year
$10.77
N/A
Revenue Next Year
$6.16
$7.27
P/E Ratio
N/A
N/A
Revenue Growth
13.24
N/A
52 Week Low
$9.67
$1.67
52 Week High
$15.84
$6.21

Technical Indicators

Market Signals
Indicator
SHEN
MRVI
Relative Strength Index (RSI) 42.83 58.83
Support Level $10.65 $3.32
Resistance Level $10.96 $3.76
Average True Range (ATR) 0.34 0.23
MACD 0.13 -0.00
Stochastic Oscillator 74.92 80.00

Price Performance

Historical Comparison
SHEN
MRVI

About SHEN Shenandoah Telecommunications Co

Shenandoah Telecommunications Company, with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: